ArticleFood science & nutrition2025
An Encapsulated Vitamin A Palmitate Powder With Improved Stability for Use in Food Fortification.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- An Encapsulated Vitamin A Palmitate Powder With Improved Stability for Use in Food Fortification.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vitamin A deficiency (VAD) is a serious health concern, particularly in low- and middle-income countries. Food fortification is hindered by the instability of vitamin A. The objective was to develop a dry form of vitamin A palmitate (VAP) with improved stability compared to marketed products. This powder could be employed for large-scale food fortification to help prevent VAD. VAP is emulsified with a variety of food-grade ingredients, including basic methacrylate copolymer (BMC). A spray-dried BMC-encapsulated VAP (PFH-VAP) was produced using laboratory-scale equipment. Subsets were assessed for determination of the VAP content and VAP recovery after cooking in water. Another subset was subjected to accelerated stability testing. Two high-performance formulations were produced at the pilot scale. The two most promising PFH-VAP formulations and a commercially available vitamin A product were each incorporated into bouillon cubes, stored (40°C, 75% relative humidity), and subjected to stability testing. The optimized laboratory-scale formulations exhibited > 90% VAP recovery after cooking. The pilot-scale batches showed 95% and 65% VAP recoveries after cooking and accelerated stability testing, respectively. After 12 months of stability testing, 70% and 68% VAP recoveries were achieved for the pilot-scale batches of PFH-VAP-fortified bouillon. A 15% VAP recovery was obtained from the bouillon fortified with a commercial product. PFH-VAP demonstrated a substantial stability advantage over an existing commercial formulation of VAP in a proof-of-concept food vehicle (bouillon). The use of PFH-VAP could increase the nutritional and health benefits of vitamin A-fortified foods and condiments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.